CRVO Insider Trading Activity and SEC Form 4 Filings
CRVO insider trading summary
Over the past 12 months, insiders at CervoMed Inc. (CRVO) reported 19 open-market purchases worth $3.7M by 5 insiders and no sales on SEC Form 4. Net insider buying was $3.7M.
Latest CRVO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Joshua S Boger | Director | Buy | $3.0M (955,414 @ $3.14) |
| Nov 18, 2025 | William Robert Elder | CFO, GC & Secretary | Buy | $21K (2,500 @ $8.32) |
| Nov 18, 2025 | Matthew Winton | Chief Commercial and Business | Buy | $12K (1,500 @ $7.95) |
| Nov 17, 2025 | John J Alam | CEO & President | Buy | $91K (10,793 @ $8.46) |
| Nov 17, 2025 | John J Alam | CEO & President | Buy | $91K (10,807 @ $8.46) |
| Nov 17, 2025 | Sylvie Gregoire | Director | Buy | $91K (10,807 @ $8.46) |
| Nov 17, 2025 | Matthew Winton | Chief Commercial and Business | Buy | $30K (3,500 @ $8.43) |
| Nov 17, 2025 | William Robert Elder | CFO, GC & Secretary | Buy | $8K (1,000 @ $8.45) |
| Nov 17, 2025 | Sylvie Gregoire | Director | Buy | $91K (10,793 @ $8.46) |
| Nov 14, 2025 | Matthew Winton | Chief Commercial and Business | Buy | $76K (10,000 @ $7.57) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.